Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 276 articles:
HTML format



Single Articles


    January 2021
  1. PTACEK J, Hawtin RE, Sun D, Louie B, et al
    Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity.
    PLoS One. 2021;16:e0244187.
    PubMed     Abstract available


  2. BECART S, Whittington KB, Prislovsky A, Rao NL, et al
    The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
    PLoS One. 2021;16:e0245541.
    PubMed     Abstract available


  3. DIAZ-RUBIO GI, Corona-Meraz FI, Madrigal-Ruiz PM, Robles-De Anda JA, et al
    CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis.
    PLoS One. 2021;16:e0246054.
    PubMed     Abstract available


  4. LEDON-LLANES L, Contreras-Yanez I, Guaracha-Basanez G, Valverde-Hernandez SS, et al
    Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study.
    PLoS One. 2021;16:e0245538.
    PubMed     Abstract available


  5. GALVEZ-SANCHEZ CM, de la Coba P, Colmenero JM, Reyes Del Paso GA, et al
    Attentional function in fibromyalgia and rheumatoid arthritis.
    PLoS One. 2021;16:e0246128.
    PubMed     Abstract available


  6. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Sominanda A, et al
    Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-alpha, IL-1beta, IL-10 and IL-17A.
    PLoS One. 2021;16:e0246111.
    PubMed     Abstract available


  7. GAURAV R, Mikuls TR, Thiele GM, Nelson AJ, et al
    High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis.
    PLoS One. 2021;16:e0240707.
    PubMed     Abstract available


  8. SHUKLA R, Ganeshani M, Agarwal M, Jangir R, et al
    Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.
    PLoS One. 2021;16:e0246195.
    PubMed     Abstract available



  9. Expression of Concern: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0247971.
    PubMed    


  10. GOSSELT HR, Vallerga CL, Mandaviya PR, Lubberts E, et al
    Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients.
    PLoS One. 2021;16:e0247709.
    PubMed     Abstract available


  11. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0248151.
    PubMed     Abstract available


  12. DREVINGE C, Scheffler JM, Koro-Arvidsson C, Sundh D, et al
    Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
    PLoS One. 2021;16:e0249205.
    PubMed     Abstract available


  13. SLOT LM, Vergroesen RD, Kerkman PF, Staudinger E, et al
    Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.
    PLoS One. 2021;16:e0247847.
    PubMed     Abstract available



  14. Correction to Expression of Concern on: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0249512.
    PubMed     Abstract available


  15. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    PubMed     Abstract available


  16. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    PubMed     Abstract available


  17. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    PubMed     Abstract available


  18. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    PubMed     Abstract available


  19. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    PubMed     Abstract available


  20. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    PubMed     Abstract available


  21. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available


  22. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    PubMed     Abstract available


  23. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    PubMed     Abstract available


  24. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    PubMed     Abstract available


  25. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    PubMed     Abstract available


  26. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    PubMed     Abstract available


  27. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed     Abstract available


  28. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed     Abstract available


  29. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    PubMed     Abstract available


  30. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    PubMed     Abstract available


  31. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
    The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
    PLoS One. 2021;16:e0246051.
    PubMed     Abstract available


    January 2020
  32. BIRKNER B, Rech J, Stargardt T
    Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0226754.
    PubMed     Abstract available


  33. CHENG YY, Chang ST, Kao CL, Chen YH, et al
    The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0227514.
    PubMed     Abstract available


  34. MURAKAMI I, Murakami K, Hashimoto M, Tanaka M, et al
    Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis.
    PLoS One. 2020;15:e0228852.
    PubMed     Abstract available


  35. KURIYA B, Vigod S, Luo J, Widdifield J, et al
    The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study.
    PLoS One. 2020;15:e0229273.
    PubMed     Abstract available


  36. MINAMINO H, Katsushima M, Yoshida T, Hashimoto M, et al
    Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database.
    PLoS One. 2020;15:e0229998.
    PubMed     Abstract available


  37. GUIMARAES MFBR, Pinto MRDC, Resende GG, Machado CJ, et al
    Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
    PLoS One. 2020;15:e0230317.
    PubMed     Abstract available


  38. KIM HC, Choi KH, Jacob J, Song JW, et al
    Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.
    PLoS One. 2020;15:e0229997.
    PubMed     Abstract available


  39. KIM HY, Park SY, Lee SW, Lee HR, et al
    Retraction: Inhibition of HMGB1-Induced Angiogenesis by Cilostazol via SIRT1 Activation in Synovial Fibroblasts from Rheumatoid Arthritis.
    PLoS One. 2020;15:e0230889.
    PubMed    


  40. ZHOU M, Xu R, Kaelber DC, Gurney ME, et al
    Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PLoS One. 2020;15:e0229819.
    PubMed     Abstract available


  41. DING J, Shi C, Bowes J, Eyre S, et al
    Exploring the overlap between rheumatoid arthritis susceptibility loci and long non-coding RNA annotations.
    PLoS One. 2020;15:e0223939.
    PubMed     Abstract available


  42. PAN Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, et al
    Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    PLoS One. 2020;15:e0231481.
    PubMed     Abstract available


  43. KHATRI S, Hansen J, Astakhova K
    Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.
    PLoS One. 2020;15:e0232010.
    PubMed     Abstract available


  44. AVOUAC J, Cauvet A, Steelandt A, Shirai Y, et al
    Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    PLoS One. 2020;15:e0232978.
    PubMed     Abstract available


  45. MOON J, Choi SH, Yoon CH, Kim MK, et al
    Gut dysbiosis is prevailing in Sjogren's syndrome and is related to dry eye severity.
    PLoS One. 2020;15:e0229029.
    PubMed     Abstract available


  46. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available


  47. KOLARZ B, Ciesla M, Dryglewska M, Rosenthal AK, et al
    Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis.
    PLoS One. 2020;15:e0233897.
    PubMed     Abstract available


  48. SACRISTAN JA, Dilla T, Diaz-Cerezo S, Gabas-Rivera C, et al
    Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.
    PLoS One. 2020;15:e0234705.
    PubMed     Abstract available


  49. ALAM J, Lee A, Lee J, Kwon DI, et al
    Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome.
    PLoS One. 2020;15:e0230667.
    PubMed     Abstract available


  50. CASANOVA-VALLVE N, Constantin-Teodosiu D, Filer A, Hardy RS, et al
    Skeletal muscle dysregulation in rheumatoid arthritis: Metabolic and molecular markers in a rodent model and patients.
    PLoS One. 2020;15:e0235702.
    PubMed     Abstract available


  51. BAGHDADI LR
    Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235637.
    PubMed     Abstract available


  52. JIRSOVA K, Seidler Stangova P, Palos M, Mahelkova G, et al
    Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjogren's syndrome.
    PLoS One. 2020;15:e0231473.
    PubMed     Abstract available


  53. ORTIZ-HARO AB, Lerma-Talamantes A, Cabrera-Vanegas A, Contreras-Yanez I, et al
    Development and validation of a questionnaire assessing household work limitations (HOWL-Q) in women with rheumatoid arthritis.
    PLoS One. 2020;15:e0236167.
    PubMed     Abstract available


  54. XINQIANG S, Erqin D, Yu Z, Hongtao D, et al
    Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis.
    PLoS One. 2020;15:e0233814.
    PubMed     Abstract available


  55. DERAMBURE C, Dzangue-Tchoupou G, D'Agostino MA, Lequerre T, et al
    Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.
    PLoS One. 2020;15:e0237143.
    PubMed     Abstract available


  56. VAN BOHEEMEN L, van Beers-Tas MH, Kroese JM, van de Stadt LA, et al
    Cardiovascular risk in persons at risk of developing rheumatoid arthritis.
    PLoS One. 2020;15:e0237072.
    PubMed     Abstract available


  57. ESBENSEN BA, Stallknecht SE, Madsen ME, Hagelund L, et al
    Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis.
    PLoS One. 2020;15:e0237117.
    PubMed     Abstract available


  58. CONTRERAS-YANEZ I, Cabrera-Vanegas A, Robledo-Torres A, Caceres-Giles C, et al
    Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0237504.
    PubMed     Abstract available


  59. BURISCH J, Eigner W, Schreiber S, Aletaha D, et al
    Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233781.
    PubMed     Abstract available


  60. PINEL L, Perez-Nieto MA, Redondo M, Rodriguez-Rodriguez L, et al
    Emotional affection on a sustained attention task: The importance the aging process and depression.
    PLoS One. 2020;15:e0234405.
    PubMed     Abstract available


  61. FOSTER E, Malloy MJ, Jokubaitis VG, Wrede CDH, et al
    Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
    PLoS One. 2020;15:e0234813.
    PubMed     Abstract available


  62. JUN JH, Lee YH, Son MJ, Kim H, et al
    Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
    PLoS One. 2020;15:e0235408.
    PubMed     Abstract available


  63. DI BENEDETTO P, Cipriani P, Iacono D, Pantano I, et al
    Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    PLoS One. 2020;15:e0235326.
    PubMed     Abstract available


  64. ASLAM MM, Jalil F, John P, Fan KH, et al
    A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases.
    PLoS One. 2020;15:e0239426.
    PubMed     Abstract available


  65. ARNTZ OJ, Pieters BCH, van Lent PLEM, Koenders MI, et al
    An optimized method for plasma extracellular vesicles isolation to exclude the copresence of biological drugs and plasma proteins which impairs their biological characterization.
    PLoS One. 2020;15:e0236508.
    PubMed     Abstract available


  66. JHUN J, Moon J, Ryu J, Shin Y, et al
    Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting.
    PLoS One. 2020;15:e0241080.
    PubMed     Abstract available


  67. CHUANG CJ, Hsu CW, Lu MC, Koo M, et al
    Increased risk of developing dental diseases in patients with primary Sjogren's syndrome-A secondary cohort analysis of population-based claims data.
    PLoS One. 2020;15:e0239442.
    PubMed     Abstract available


  68. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available


  69. MORI S, Koga Y, Nakamura K, Hirooka S, et al
    Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.
    PLoS One. 2020;15:e0243110.
    PubMed     Abstract available


  70. TEITSMA XM, Devenport J, Jacobs JWG, Petho-Schramm A, et al
    Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.
    PLoS One. 2020;15:e0241189.
    PubMed     Abstract available


  71. BAGHDADI LR
    Correction: Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243960.
    PubMed     Abstract available


  72. MORI A, Saito T, Takahashi M, Shibata M, et al
    Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0243729.
    PubMed     Abstract available


  73. DROZ N, Hanaway P, Hyman M, Jin Y, et al
    The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective study.
    PLoS One. 2020;15:e0240416.
    PubMed     Abstract available


  74. SHOJI J, Inada N, Tomioka A, Yamagami S, et al
    Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjogren's syndrome-associated dry eyes.
    PLoS One. 2020;15:e0242617.
    PubMed     Abstract available


  75. GATT A, Mercieca C, Borg A, Grech A, et al
    Thermal characteristics of rheumatoid feet in remission: Baseline data.
    PLoS One. 2020;15:e0243078.
    PubMed     Abstract available


  76. KOO H, Morrow CD
    Perturbation of the human gastrointestinal tract microbial ecosystem by oral drugs to treat chronic disease results in a spectrum of individual specific patterns of extinction and persistence of dominant microbial strains.
    PLoS One. 2020;15:e0242021.
    PubMed     Abstract available


  77. BUSCHHART AL, Bolten L, Volzke J, Ekat K, et al
    Periodontal pathogens alter the synovial proteome. Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice.
    PLoS One. 2020;15:e0242868.
    PubMed     Abstract available


  78. BEN-ELI H, Solomon A, Aframian DJ, Ben-Chetrit E, et al
    Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    PLoS One. 2020;15:e0244712.
    PubMed     Abstract available


    January 2019
  79. CHOI IA, Lee JS, Song YW, Lee EY, et al
    Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study.
    PLoS One. 2019;14:e0210471.
    PubMed     Abstract available


  80. CHU KA, Chen W, Hsu CY, Hung YM, et al
    Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan.
    PLoS One. 2019;14:e0210750.
    PubMed     Abstract available


  81. LILLEGRAVEN S, Greenberg JD, Reed GW, Saunders K, et al
    Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
    PLoS One. 2019;14:e0210459.
    PubMed     Abstract available


  82. TOKAI N, Yoshida S, Kotani T, Yoshikawa A, et al
    Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    PLoS One. 2019;14:e0211750.
    PubMed     Abstract available


  83. RAZI B, Reykandeh SE, Alizadeh S, Amirzargar A, et al
    TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0211146.
    PubMed     Abstract available


  84. GOMIDES APM, de Albuquerque CP, Santos ABV, Amorim RBC, et al
    Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    PLoS One. 2019;14:e0213219.
    PubMed     Abstract available


  85. GASSERT FT, Gassert FG, Topping GJ, Rummeny EJ, et al
    SNR analysis of contrast-enhanced MR imaging for early detection of rheumatoid arthritis.
    PLoS One. 2019;14:e0213082.
    PubMed     Abstract available


  86. FERREIRO-IGLESIAS A, Montes A, Perez-Pampin E, Canete JD, et al
    Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    PLoS One. 2019;14:e0213073.
    PubMed     Abstract available


  87. VEYSSIERE M, Perea J, Michou L, Boland A, et al
    A novel nonsense variant in SUPT20H gene associated with Rheumatoid Arthritis identified by Whole Exome Sequencing of multiplex families.
    PLoS One. 2019;14:e0213387.
    PubMed     Abstract available


  88. BADR MT, Hacker G
    Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.
    PLoS One. 2019;14:e0213470.
    PubMed     Abstract available


  89. DARGHAM SR, Zahirovic S, Hammoudeh M, Al Emadi S, et al
    Correction: Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    PLoS One. 2019;14:e0214258.
    PubMed     Abstract available


  90. GOMIDES APM, de Albuquerque CP, Santos ABV, Amorim RBC, et al
    Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    PLoS One. 2019;14:e0215198.
    PubMed     Abstract available


  91. MAKIN K, Easter T, Kemp M, Kendall P, et al
    Undetectable mannose binding lectin is associated with HRCT proven bronchiectasis in rheumatoid arthritis (RA).
    PLoS One. 2019;14:e0215051.
    PubMed     Abstract available


  92. GONZALEZ-ALVARO I, Castrejon I, Carmona L
    The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity.
    PLoS One. 2019;14:e0214717.
    PubMed     Abstract available


  93. SUNG YK, Yoshida K, Prince FHM, Frits ML, et al
    Prevalence and predictors for sustained remission in rheumatoid arthritis.
    PLoS One. 2019;14:e0214981.
    PubMed     Abstract available


  94. HARRISON M, Spooner L, Bansback N, Milbers K, et al
    Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individuals.
    PLoS One. 2019;14:e0216075.
    PubMed     Abstract available


  95. GARCIA-MORENO C, Gomara MJ, Bleda MJ, Sanmarti R, et al
    Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.
    PLoS One. 2019;14:e0215927.
    PubMed     Abstract available


  96. EBINA K, Hashimoto M, Yamamoto W, Hirano T, et al
    Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.
    PLoS One. 2019;14:e0216624.
    PubMed     Abstract available


  97. PAN Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, et al
    Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    PLoS One. 2019;14:e0215999.
    PubMed     Abstract available


  98. ENGLBRECHT M, Alten R, Aringer M, Baerwald CG, et al
    New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.
    PLoS One. 2019;14:e0217412.
    PubMed     Abstract available


  99. HOLMES CL, Peyton CG, Bier AM, Donlon TZ, et al
    Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.
    PLoS One. 2019;14:e0217221.
    PubMed     Abstract available


  100. VLIETSTRA L, Stebbings S, Meredith-Jones K, Abbott JH, et al
    Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity.
    PLoS One. 2019;14:e0217462.
    PubMed     Abstract available


  101. PILGAARD T, Hagelund L, Stallknecht SE, Jensen HH, et al
    Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study.
    PLoS One. 2019;14:e0218831.
    PubMed     Abstract available


  102. SASAKI C, Hiraishi T, Oku T, Okuma K, et al
    Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis.
    PLoS One. 2019;14:e0219400.
    PubMed     Abstract available


  103. PLATZER A, Nussbaumer T, Karonitsch T, Smolen JS, et al
    Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns.
    PLoS One. 2019;14:e0219698.
    PubMed     Abstract available


  104. HUOPONEN S, Aaltonen KJ, Viikinkoski J, Rutanen J, et al
    Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.
    PLoS One. 2019;14:e0220142.
    PubMed     Abstract available


  105. CONTRERAS-YANEZ I, Lavielle P, Clark P, Pascual-Ramos V, et al
    Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis.
    PLoS One. 2019;14:e0219921.
    PubMed     Abstract available


  106. SODERGREN A, Karp K, Bengtsson C, Moller B, et al
    Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis.
    PLoS One. 2019;14:e0220531.
    PubMed     Abstract available


  107. MAK VP, Siu AM, Choi SY, Jun Ahn H, et al
    Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis.
    PLoS One. 2019;14:e0220978.
    PubMed     Abstract available


  108. SUNG YK, Yoshida K, Prince FHM, Frits ML, et al
    Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
    PLoS One. 2019;14:e0221314.
    PubMed     Abstract available


  109. BUJOR AM, Janjua S, LaValley MP, Duran J, et al
    Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis.
    PLoS One. 2019;14:e0221823.
    PubMed     Abstract available


  110. ANAPARTI V, Meng X, Hemshekhar M, Smolik I, et al
    Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis.
    PLoS One. 2019;14:e0219109.
    PubMed     Abstract available


  111. BRUIJNEN STG, Verweij NJF, Gent YYJ, Huisman MC, et al
    Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers.
    PLoS One. 2019;14:e0222844.
    PubMed     Abstract available


  112. VILAR KM, Pereira MC, Tavares Dantas A, de Melo Rego MJB, et al
    Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients.
    PLoS One. 2019;14:e0223191.
    PubMed     Abstract available


  113. TRAYLOR M, Knevel R, Cui J, Taylor J, et al
    Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.
    PLoS One. 2019;14:e0223246.
    PubMed     Abstract available


  114. CARUBBI F, Alunno A, Cipriani P, Coletti G, et al
    Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjogren's syndrome minor salivary glands.
    PLoS One. 2019;14:e0211142.
    PubMed     Abstract available


  115. PANGA V, Kallor AA, Nair A, Harshan S, et al
    Mitochondrial dysfunction in rheumatoid arthritis: A comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data.
    PLoS One. 2019;14:e0224632.
    PubMed     Abstract available


  116. HAMMAD DBM, Liyanapathirana V, Tonge DP
    Molecular characterisation of the synovial fluid microbiome in rheumatoid arthritis patients and healthy control subjects.
    PLoS One. 2019;14:e0225110.
    PubMed     Abstract available


  117. MAEDA S, Osaga S, Maeda T, Takeda N, et al
    Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.
    PLoS One. 2019;14:e0215192.
    PubMed     Abstract available


  118. MILIC V, Grujic M, Barisic J, Marinkovic-Eric J, et al
    Personality, depression and anxiety in primary Sjogren's syndrome - Association with sociodemographic factors and comorbidity.
    PLoS One. 2019;14:e0210466.
    PubMed     Abstract available


  119. RAMIREZ-BELLO J, Sun C, Valencia-Pacheco G, Singh B, et al
    ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico.
    PLoS One. 2019;14:e0224543.
    PubMed     Abstract available


  120. SOULIOTIS K, Golna C, Kani C, Nikolaidi S, et al
    Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece.
    PLoS One. 2019;14:e0226287.
    PubMed     Abstract available


  121. TEHAN PE, Taylor WJ, Carroll M, Dalbeth N, et al
    Important features of retail shoes for women with rheumatoid arthritis: A Delphi consensus survey.
    PLoS One. 2019;14:e0226906.
    PubMed     Abstract available


  122. CHANDRAN U, Reps J, Stang PE, Ryan PB, et al
    Inferring disease severity in rheumatoid arthritis using predictive modeling in administrative claims databases.
    PLoS One. 2019;14:e0226255.
    PubMed     Abstract available


  123. RAKNES G, Smabrekke L
    Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
    PLoS One. 2019;14:e0212460.
    PubMed     Abstract available


  124. PAN TC, Tsai YH, Chen WC, Hsieh YL, et al
    The effects of laser acupuncture on the modulation of cartilage extracellular matrix macromolecules in rats with adjuvant-induced arthritis.
    PLoS One. 2019;14:e0211341.
    PubMed     Abstract available


  125. MAIBOM-THOMSEN SL, Trier NH, Holm BE, Hansen KB, et al
    Immunoglobulin G structure and rheumatoid factor epitopes.
    PLoS One. 2019;14:e0217624.
    PubMed     Abstract available


  126. RUSTHEN S, Kristoffersen AK, Young A, Galtung HK, et al
    Dysbiotic salivary microbiota in dry mouth and primary Sjogren's syndrome patients.
    PLoS One. 2019;14:e0218319.
    PubMed     Abstract available


  127. BLAIR JPM, Bager C, Platt A, Karsdal M, et al
    Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies.
    PLoS One. 2019;14:e0219980.
    PubMed     Abstract available


  128. VAN HEUCKELUM M, Linn AJ, Vandeberg L, Hebing RCF, et al
    Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence.
    PLoS One. 2019;14:e0221290.
    PubMed     Abstract available


  129. CASTAGNE B, Viprey M, Martin J, Schott AM, et al
    Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis.
    PLoS One. 2019;14:e0220178.
    PubMed     Abstract available


  130. AHN SS, Lee B, Kim D, Jung SM, et al
    Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria.
    PLoS One. 2019;14:e0219970.
    PubMed     Abstract available


  131. GUISADO-VASCO P, Silva M, Duarte-Millan MA, Sambataro G, et al
    Quantitative assessment of interstitial lung disease in Sjogren's syndrome.
    PLoS One. 2019;14:e0224772.
    PubMed     Abstract available


  132. LEE CK, Tsai CP, Liao TL, Huang WN, et al
    Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjogren's syndrome patients: A nationwide population-based study.
    PLoS One. 2019;14:e0225455.
    PubMed     Abstract available


  133. MILIC V, Colic J, Cirkovic A, Stanojlovic S, et al
    Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    PLoS One. 2019;14:e0226498.
    PubMed     Abstract available


    January 2018
  134. FENG X, Tian M, Zhang W, Mei H, et al
    Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.
    PLoS One. 2018;13:e0190798.
    PubMed     Abstract available


  135. LIN TM, Chen WS, Sheu JJ, Chen YH, et al
    Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study.
    PLoS One. 2018;13:e0186475.
    PubMed     Abstract available


  136. TERATO K, Waritani T, Fukai R, Shionoya H, et al
    Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis.
    PLoS One. 2018;13:e0190588.
    PubMed     Abstract available


  137. KANEKO C, Kobayashi T, Ito S, Sugita N, et al
    Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study.
    PLoS One. 2018;13:e0192365.
    PubMed     Abstract available


  138. BELL RD, Rudmann C, Wood RW, Schwarz EM, et al
    Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice.
    PLoS One. 2018;13:e0190678.
    PubMed     Abstract available


  139. GUO Y, Walsh AM, Canavan M, Wechalekar MD, et al
    Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.
    PLoS One. 2018;13:e0192704.
    PubMed     Abstract available


  140. DE JONG HJI, Cohen Tervaert JW, Lalmohamed A, de Vries F, et al
    Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.
    PLoS One. 2018;13:e0193297.
    PubMed     Abstract available


  141. HUA J, Huang W
    Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations.
    PLoS One. 2018;13:e0193674.
    PubMed     Abstract available


  142. TAVERNER D, Vallve JC, Ferre R, Paredes S, et al
    Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.
    PLoS One. 2018;13:e0193690.
    PubMed     Abstract available


  143. EBINA K, Hashimoto M, Yamamoto W, Ohnishi A, et al
    Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
    PLoS One. 2018;13:e0194130.
    PubMed     Abstract available


  144. AUDO R, Deckert V, Daien CI, Che H, et al
    PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.
    PLoS One. 2018;13:e0193815.
    PubMed     Abstract available


  145. SUZUKI K, Nakashima A, Igarashi M, Saito K, et al
    Euglena gracilis Z and its carbohydrate storage substance relieve arthritis symptoms by modulating Th17 immunity.
    PLoS One. 2018;13:e0191462.
    PubMed     Abstract available


  146. DHAOUADI T, Chahbi M, Haouami Y, Sfar I, et al
    IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0194883.
    PubMed     Abstract available


  147. MORITA Y, Ito H, Torii M, Hanai A, et al
    Factors affecting walking ability in female patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0195059.
    PubMed     Abstract available


  148. MACIAS-SEGURA N, Castaneda-Delgado JE, Bastian Y, Santiago-Algarra D, et al
    Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.
    PLoS One. 2018;13:e0194205.
    PubMed     Abstract available


  149. CHOI ST, Lee KH
    Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    PLoS One. 2018;13:e0195550.
    PubMed     Abstract available


  150. SHI Q, Li KJ, Treuer T, Wang BCM, et al
    Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD).
    PLoS One. 2018;13:e0193489.
    PubMed     Abstract available


  151. UUTELA TI, Kautiainen HJ, Hakkinen AH
    Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0194917.
    PubMed     Abstract available


  152. OTSUKA Y, Kiyohara C, Kashiwado Y, Sawabe T, et al
    Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
    PLoS One. 2018;13:e0196368.
    PubMed     Abstract available


  153. LOPEZ-RODRIGUEZ R, Perez-Pampin E, Marquez A, Blanco FJ, et al
    Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
    PLoS One. 2018;13:e0196793.
    PubMed     Abstract available


  154. GHITI MOGHADAM M, Lamers-Karnebeek FBG, Vonkeman HE, Ten Klooster PM, et al
    Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.
    PLoS One. 2018;13:e0192425.
    PubMed     Abstract available


  155. ANDERSEN M, Boesen M, Ellegaard K, Soderstrom K, et al
    Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.
    PLoS One. 2018;13:e0197001.
    PubMed     Abstract available


  156. LOPES AP, Hillen MR, Chouri E, Blokland SLM, et al
    Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren's syndrome.
    PLoS One. 2018;13:e0193157.
    PubMed     Abstract available


  157. PANEZAI J, Ghaffar A, Altamash M, Engstrom PE, et al
    Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0197235.
    PubMed     Abstract available


  158. PANGA V, Raghunathan S
    A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis.
    PLoS One. 2018;13:e0199530.
    PubMed     Abstract available


  159. CHOI S, Lee KH
    Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    PLoS One. 2018;13:e0199468.
    PubMed     Abstract available


  160. HUGHES-AUSTIN JM, Deane KD, Giles JT, Derber LA, et al
    Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients.
    PLoS One. 2018;13:e0199578.
    PubMed     Abstract available


  161. KIM JY, Lim K, Kim KH, Kim JH, et al
    N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis.
    PLoS One. 2018;13:e0194331.
    PubMed     Abstract available


  162. SCHARMGA A, Peters M, van den Bergh JP, Geusens P, et al
    Development of a scoring method to visually score cortical interruptions on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis and healthy controls.
    PLoS One. 2018;13:e0200331.
    PubMed     Abstract available


  163. TSUJIMOTO S, Mokuda S, Matoba K, Yamada A, et al
    The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0200023.
    PubMed     Abstract available


  164. CHEN KC, Wu CH, Tang CH, Huang KC, et al
    Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database.
    PLoS One. 2018;13:e0200758.
    PubMed     Abstract available


  165. CHIU YM, Lai MS, Chan KA
    Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
    PLoS One. 2018;13:e0196210.
    PubMed     Abstract available


  166. TAKAGI Y, Nakamura H, Sumi M, Shimizu T, et al
    Combined classification system based on ACR/EULAR and ultrasonographic scores for improving the diagnosis of Sjogren's syndrome.
    PLoS One. 2018;13:e0195113.
    PubMed     Abstract available


  167. LINDNER MD, Torralba KD, Khan NA
    Scientific productivity: An exploratory study of metrics and incentives.
    PLoS One. 2018;13:e0195321.
    PubMed     Abstract available


  168. LIU M, Degner J, Davis JW, Idler KB, et al
    Identification of HLA-DRB1 association to adalimumab immunogenicity.
    PLoS One. 2018;13:e0195325.
    PubMed     Abstract available


  169. WHEATER G, Elshahaly M, Naraghi K, Tuck SP, et al
    Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study.
    PLoS One. 2018;13:e0201527.
    PubMed     Abstract available


  170. WAKABAYASHI A, Ishiguro T, Takaku Y, Miyahara Y, et al
    Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0201799.
    PubMed     Abstract available


  171. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    Differential effects of TNF-alpha and IL-1beta on the control of metal metabolism and cadmium-induced cell death in chronic inflammation.
    PLoS One. 2018;13:e0196285.
    PubMed     Abstract available


  172. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    PubMed     Abstract available


  173. TOKAI N, Yoshida S, Kotani T, Yoshikawa A, et al
    Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0202601.
    PubMed     Abstract available


  174. OMA I, Olstad OK, Andersen JK, Lyberg T, et al
    Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis.
    PLoS One. 2018;13:e0202346.
    PubMed     Abstract available


  175. LEBLOND A, Pezet S, Trouvin AP, Elhai M, et al
    Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.
    PLoS One. 2018;13:e0203607.
    PubMed     Abstract available


  176. YANO K, Ikari K, Inoue E, Sakuma Y, et al
    Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort.
    PLoS One. 2018;13:e0202427.
    PubMed     Abstract available


  177. FURUKAWA H, Oka S, Shimada K, Hashimoto A, et al
    Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations.
    PLoS One. 2018;13:e0204459.
    PubMed     Abstract available


  178. HARTJEN N, Brauer L, Reiss B, Claassen H, et al
    Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
    PLoS One. 2018;13:e0203502.
    PubMed     Abstract available


  179. BEYER K, Zaura E, Brandt BW, Buijs MJ, et al
    Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health.
    PLoS One. 2018;13:e0202278.
    PubMed     Abstract available



  180. Retraction: Identification of Autoantibodies against Transthyretin for the Screening and Diagnosis of Rheumatoid Arthritis.
    PLoS One. 2018;13:e0205914.
    PubMed    


  181. VOGELZANG EH, Hebing RCF, Nurmohamed MT, van Kuijk AWR, et al
    Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
    PLoS One. 2018;13:e0205125.
    PubMed     Abstract available


  182. ALEMAO E, Al MJ, Boonen AA, Stevenson MD, et al
    Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.
    PLoS One. 2018;13:e0205013.
    PubMed     Abstract available


  183. JUNG SM, Kwok SK, Ju JH, Lee SW, et al
    Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry.
    PLoS One. 2018;13:e0205651.
    PubMed     Abstract available


  184. WATERBORG CEJ, Koenders MI, van Lent PLEM, van der Kraan PM, et al
    Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
    PLoS One. 2018;13:e0205902.
    PubMed     Abstract available


  185. NAKAGAWA S, Nakaishi M, Hashimoto M, Ito H, et al
    Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.
    PLoS One. 2018;13:e0206943.
    PubMed     Abstract available


  186. SATO T, Hatano M, Iwasaki Y, Maki H, et al
    Prevalence of primary Sjogren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.
    PLoS One. 2018;13:e0197297.
    PubMed     Abstract available


  187. CHIN CY, Hsieh SY, Tseng VS
    eDRAM: Effective early disease risk assessment with matrix factorization on a large-scale medical database: A case study on rheumatoid arthritis.
    PLoS One. 2018;13:e0207579.
    PubMed     Abstract available


  188. MASUOKA S, Kusunoki N, Takamatsu R, Takahashi H, et al
    Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovialtissues of rheumatoid arthritis.
    PLoS One. 2018;13:e0208957.
    PubMed     Abstract available


  189. DE ROTTE MCFJ, Pluijm SMF, de Jong PHP, Bulatovic Calasan M, et al
    Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    PLoS One. 2018;13:e0208534.
    PubMed     Abstract available


  190. DARGHAM SR, Zahirovic S, Hammoudeh M, Al Emadi S, et al
    Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    PLoS One. 2018;13:e0208240.
    PubMed     Abstract available


  191. JEONG DH, Kang J, Jung YJ, Yoo B, et al
    Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    PLoS One. 2018;13:e0198756.
    PubMed     Abstract available


  192. SU H, Rei N, Zhang L, Cheng J, et al
    Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases.
    PLoS One. 2018;13:e0198693.
    PubMed     Abstract available


  193. SAAD MN, Mabrouk MS, Eldeib AM, Shaker OG, et al
    Comparative study for haplotype block partitioning methods - Evidence from chromosome 6 of the North American Rheumatoid Arthritis Consortium (NARAC) dataset.
    PLoS One. 2018;13:e0209603.
    PubMed     Abstract available


  194. WANG X, Shaalan A, Liefers S, Coudenys J, et al
    Dysregulation of NF-kB in glandular epithelial cells results in Sjogren's-like features.
    PLoS One. 2018;13:e0200212.
    PubMed     Abstract available


  195. CHEN HH, Chao WC, Liao TL, Lin CH, et al
    Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
    PLoS One. 2018;13:e0201340.
    PubMed     Abstract available


  196. MCKELVEY KJ, Millier MJ, Doyle TC, Stamp LK, et al
    Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation.
    PLoS One. 2018;13:e0202135.
    PubMed     Abstract available


  197. REGUEIRO C, Ortiz AM, Boveda MD, Castaneda S, et al
    Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
    PLoS One. 2018;13:e0202583.
    PubMed     Abstract available


  198. TAKAMURA Y, Aoki W, Satomura A, Shibasaki S, et al
    Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-alpha stimulation.
    PLoS One. 2018;13:e0201851.
    PubMed     Abstract available


  199. SCHRIMPF A, Brodje D, Pfefferle P, Geyer A, et al
    A set of conformationally well-defined L/D-peptide epitopes provides a serological bar code for autoantibody subtypes.
    PLoS One. 2018;13:e0201735.
    PubMed     Abstract available


  200. DAMGAARD D, Bawadekar M, Senolt L, Stensballe A, et al
    Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    PLoS One. 2018;13:e0203214.
    PubMed     Abstract available


  201. WOLFE F, Walitt B, Perrot S, Rasker JJ, et al
    Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias.
    PLoS One. 2018;13:e0203755.
    PubMed     Abstract available


  202. AQRAWI LA, Chen X, Jensen JL, Morthen MK, et al
    Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjogren's syndrome.
    PLoS One. 2018;13:e0205762.
    PubMed     Abstract available


    January 2017
  203. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0174656.
    PubMed     Abstract available


  204. HALLAJZADEH J, Safiri S, Mansournia MA, Khoramdad M, et al
    Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.
    PLoS One. 2017;12:e0170361.
    PubMed     Abstract available


  205. PARADOWSKA-GORYCKA A, Sowinska A, Pawlik A, Malinowski D, et al
    FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.
    PLoS One. 2017;12:e0172018.
    PubMed     Abstract available


  206. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0175605.
    PubMed     Abstract available


  207. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Abstract available


  208. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    PLoS One. 2017;12:e0175207.
    PubMed     Abstract available


  209. BOO S, Oh H, Froelicher ES, Suh CH, et al
    Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0176291.
    PubMed     Abstract available


  210. IWAMOTO N, Tsuji S, Takatani A, Shimizu T, et al
    Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0177057.
    PubMed     Abstract available


  211. KOGA T, Okada A, Fukuda T, Hidaka T, et al
    Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.
    PLoS One. 2017;12:e0175281.
    PubMed     Abstract available


  212. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0178309.
    PubMed     Abstract available


  213. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Abstract available


  214. MORI S, Yoshitama T, Hidaka T, Sakai F, et al
    Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
    PLoS One. 2017;12:e0179179.
    PubMed     Abstract available


  215. MATEEN S, Moin S, Shahzad S, Khan AQ, et al
    Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species.
    PLoS One. 2017;12:e0178879.
    PubMed     Abstract available


  216. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventi
    PLoS One. 2017;12:e0179308.
    PubMed     Abstract available


  217. BUONDONNO I, Rovera G, Sassi F, Rigoni MM, et al
    Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.
    PLoS One. 2017;12:e0178463.
    PubMed     Abstract available


  218. HUNG YM, Lin L, Chen CM, Chiou JY, et al
    The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.
    PLoS One. 2017;12:e0179081.
    PubMed     Abstract available


  219. ZOU K, Xiao FK, Li HY, Zhou Q, et al
    Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years.
    PLoS One. 2017;12:e0180376.
    PubMed     Abstract available


  220. VIDAL-BRALO L, Perez-Pampin E, Regueiro C, Montes A, et al
    Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
    PLoS One. 2017;12:e0180144.
    PubMed     Abstract available


  221. MURPHY D, Mattey D, Hutchinson D
    Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    PLoS One. 2017;12:e0180655.
    PubMed     Abstract available


  222. LOUPASAKIS K, Kuo D, Sokhi UK, Sohn C, et al
    Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0179762.
    PubMed     Abstract available


  223. RUSCITTI P, Ursini F, Cipriani P, Liakouli V, et al
    Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
    PLoS One. 2017;12:e0181203.
    PubMed     Abstract available


  224. WANG W, Liu J, Yang B, Ma Z, et al
    Modulation of platelet-derived microparticles to adhesion and motility of human rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0181003.
    PubMed     Abstract available


  225. HUANG CM, Chen HH, Chen DC, Huang YC, et al
    Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein.
    PLoS One. 2017;12:e0180604.
    PubMed     Abstract available


  226. GILLOOLY KM, Pulicicchio C, Pattoli MA, Cheng L, et al
    Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
    PLoS One. 2017;12:e0181782.
    PubMed     Abstract available


  227. LUUKKONEN J, Pascual LM, Patlaka C, Lang P, et al
    Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
    PLoS One. 2017;12:e0182904.
    PubMed     Abstract available


  228. VAANANEN T, Vuolteenaho K, Kautiainen H, Nieminen R, et al
    Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.
    PLoS One. 2017;12:e0183294.
    PubMed     Abstract available


  229. TUNG CH, Lu MC, Lai NS, Wu SF, et al
    Tumor necrosis factor-alpha blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.
    PLoS One. 2017;12:e0183726.
    PubMed     Abstract available


  230. HURNAKOVA J, Hulejova H, Zavada J, Hanova P, et al
    Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
    PLoS One. 2017;12:e0183420.
    PubMed     Abstract available


  231. CHEN JQ, Papp G, Poliska S, Szabo K, et al
    MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren's syndrome.
    PLoS One. 2017;12:e0174585.
    PubMed     Abstract available


  232. JEONG S, Yang H, Hwang H
    Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.
    PLoS One. 2017;12:e0173597.
    PubMed     Abstract available


  233. STONE DU, Fife D, Brown M, Earley KE, et al
    Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjogren's Syndrome.
    PLoS One. 2017;12:e0170249.
    PubMed     Abstract available


  234. PASMA A, Schenk C, Timman R, van 't Spijker A, et al
    Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?
    PLoS One. 2017;12:e0171070.
    PubMed     Abstract available


  235. WOO HJ, Yu C, Reifman J
    Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases.
    PLoS One. 2017;12:e0169918.
    PubMed     Abstract available


  236. WALSH AM, Wechalekar MD, Guo Y, Yin X, et al
    Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
    PLoS One. 2017;12:e0183928.
    PubMed     Abstract available


  237. ZHOU R, Lin X, Li DY, Wang XF, et al
    Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach.
    PLoS One. 2017;12:e0183842.
    PubMed     Abstract available


  238. EBINA K, Hirao M, Takagi K, Ueno S, et al
    Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0183805.
    PubMed     Abstract available


  239. LIU R, Gao C, Chen H, Li Y, et al
    Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
    PLoS One. 2017;12:e0173301.
    PubMed     Abstract available


  240. SHIELDS KJ, Mollnes TE, Eidet JR, Mikkelsen K, et al
    Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.
    PLoS One. 2017;12:e0174577.
    PubMed     Abstract available


  241. LACKNER A, Ficjan A, Stradner MH, Hermann J, et al
    It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjogren's Syndrome - A qualitative study.
    PLoS One. 2017;12:e0172056.
    PubMed     Abstract available


  242. MORIYA N, Shibasaki S, Karasaki M, Iwasaki T, et al
    The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.
    PLoS One. 2017;12:e0169702.
    PubMed     Abstract available


  243. MOURA RA, Quaresma C, Vieira AR, Goncalves MJ, et al
    B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
    PLoS One. 2017;12:e0182927.
    PubMed     Abstract available


  244. SCRIVO R, Massaro L, Barbati C, Vomero M, et al
    The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
    PLoS One. 2017;12:e0184449.
    PubMed     Abstract available


  245. PETERS M, Scharmga A, de Jong J, van Tubergen A, et al
    An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints.
    PLoS One. 2017;12:e0175829.
    PubMed     Abstract available


  246. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Abstract available


  247. QU S, Du Y, Chang S, Guo L, et al
    Common variants near IKZF1 are associated with primary Sjogren's syndrome in Han Chinese.
    PLoS One. 2017;12:e0177320.
    PubMed     Abstract available


  248. CHAO WC, Lin CH, Liao TL, Chen YM, et al
    Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren's syndrome: A nationwide, population-based case-control study.
    PLoS One. 2017;12:e0176549.
    PubMed     Abstract available


  249. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation.
    PLoS One. 2017;12:e0180879.
    PubMed     Abstract available


  250. FIDELIX T, Czapkowski A, Azjen S, Andriolo A, et al
    Salivary gland ultrasonography as a predictor of clinical activity in Sjogren's syndrome.
    PLoS One. 2017;12:e0182287.
    PubMed     Abstract available


  251. RIFBJERG-MADSEN S, Christensen AW, Christensen R, Hetland ML, et al
    Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
    PLoS One. 2017;12:e0180014.
    PubMed     Abstract available


  252. HUANG LG, Chen G, Chen DY, Chen HH, et al
    Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186346.
    PubMed     Abstract available


  253. MAROUEN S, du Cailar G, Audo R, Lukas C, et al
    Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls.
    PLoS One. 2017;12:e0186157.
    PubMed     Abstract available


  254. JARDEL S, Fabien N, Hot A, Vukusic S, et al
    Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey.
    PLoS One. 2017;12:e0185104.
    PubMed     Abstract available


  255. CHEN FY, Lee A, Ge S, Nathan S, et al
    Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome.
    PLoS One. 2017;12:e0184916.
    PubMed     Abstract available


  256. CHEN X, Utheim OA, Xiao J, Adil MY, et al
    Meibomian gland features in a Norwegian cohort of patients with primary Sjogren s syndrome.
    PLoS One. 2017;12:e0184284.
    PubMed     Abstract available


  257. LIN CH, Chen DY, Chao WC, Liao TL, et al
    Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0182284.
    PubMed     Abstract available


  258. MENG Z, Klinngam W, Edman MC, Hamm-Alvarez SF, et al
    Interferon-gamma treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjogren's Syndrome.
    PLoS One. 2017;12:e0184781.
    PubMed     Abstract available


  259. KIM KH, Kim DH, Jeong HJ, Ryu JS, et al
    Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjgren's syndrome.
    PLoS One. 2017;12:e0183678.
    PubMed     Abstract available


  260. NARAYAN N, Mandhair H, Smyth E, Dakin SG, et al
    The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages.
    PLoS One. 2017;12:e0185767.
    PubMed     Abstract available


  261. STACK JR, Madigan A, Helbert L, Dunne E, et al
    Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    PLoS One. 2017;12:e0188027.
    PubMed     Abstract available


  262. YUAN M, Wang S, Yu L, Qu B, et al
    Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186795.
    PubMed     Abstract available


  263. STACK RJ, Southworth S, Fisher BA, Barone F, et al
    A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome.
    PLoS One. 2017;12:e0187272.
    PubMed     Abstract available


  264. CHEN YM, Chen HH, Huang WN, Liao TL, et al
    Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
    PLoS One. 2017;12:e0188454.
    PubMed     Abstract available


  265. LIN TT, Wu CK, Liao MT, Yang YH, et al
    Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
    PLoS One. 2017;12:e0188720.
    PubMed     Abstract available


  266. BEALS C, Baumgartner R, Peterfy C, Balanescu A, et al
    Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
    PLoS One. 2017;12:e0187397.
    PubMed     Abstract available


  267. HORNBERG K, Sundstrom B, Innala L, Rantapaa-Dahlqvist S, et al
    Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.
    PLoS One. 2017;12:e0190211.
    PubMed     Abstract available


  268. DUHN PH, Sode J, Hagen CM, Christiansen M, et al
    Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations.
    PLoS One. 2017;12:e0188492.
    PubMed     Abstract available


  269. WANG B, Zhao P, Zhou Y, Meng L, et al
    Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats.
    PLoS One. 2017;12:e0188199.
    PubMed     Abstract available


  270. SCHAAL JB, Tran DQ, Subramanian A, Patel R, et al
    Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide.
    PLoS One. 2017;12:e0187868.
    PubMed     Abstract available


  271. HORNUM L, Hansen AJ, Tornehave D, Fjording MS, et al
    C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    PLoS One. 2017;12:e0189017.
    PubMed     Abstract available


  272. ALMEIDA D, Vianna K, Arriaga P, Moraschini V, et al
    Dental implants in Sjogren's syndrome patients: A systematic review.
    PLoS One. 2017;12:e0189507.
    PubMed     Abstract available


    January 2016
  273. MORI S, Hidaka M, Kawakita T, Hidaka T, et al
    Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    PLoS One. 2016;11:e0154744.
    PubMed     Abstract available


  274. MANOUSEK J, Stejskal V, Kubena P, Jarkovsky J, et al
    Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome - Is There a Clinical Relevance?
    PLoS One. 2016;11:e0164786.
    PubMed     Abstract available


  275. CHEN J, Zhao X, Liu H, Zhou S, et al
    A Point-Scoring System for the Clinical Diagnosis of Sjogren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland.
    PLoS One. 2016;11:e0155666.
    PubMed     Abstract available


  276. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0161958.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: